Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate

Lesley A. Stevens, Josef Coresh, Tom Greene et al. · New England Journal of Medicine · 2006 · 3K citations

Medicine, Nephrology, Hemodialysis +15

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine.

Michael G. Stabin, Richard Sparks, Eric A. Crowe · PubMed · 2005 · 1.4K citations

Medicine, Internal Medicine, Nuclear Medicine +14

Radiolabeled Somatostatin Analog [¹⁷⁷Lu-DOTA⁰,Tyr³]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

Dik J. Kwekkeboom, Jaap J.M. Teunissen, Willem H. Bakker et al. · Journal of Clinical Oncology · 2005 · 659 citations · Full text

Medicine, Oncology, Pharmacology +15

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.

J A Siegel, Sylvia Thomas, James B. Stubbs et al. · PubMed · 1999 · 575 citations

Medicine, Nuclear Medicine, Radiology +16

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

Christian Waldherr, Miklos Pless, Helmut R. Maëcke et al. · PubMed · 2002 · 446 citations

Medicine, Oncology, Pharmacology +15